1st Quarter - Report
EISAI INC. for EISAI INC.
Firm
Client
Income
—
Expenses
$730,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Obesity awareness as a medical condition Metastatic breast cancer awareness
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | — |
Financial Institutions/Investments/Securities FIN
Student Loan Auction Rate Securities
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
Education EDU
Student Loan Auction Rate Securities
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
Pharmacy PHA
FDA-DEA controlled substances scheduling processes "Track and Trace" legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | — |
Medicare/Medicaid MMM
Coverage and reimbursement issues Average Sales Price reduction for Medicare Part B products Repeal Medicare Part D coverage exclusion for obesity drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER NORMAN | — |
| KATIE OPPENHEIM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.